ResMed Net Income 2006-2018 | RMD

ResMed annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • ResMed net income for the quarter ending December 31, 2018 was $0.125B, a 1208.27% increase year-over-year.
  • ResMed net income for the twelve months ending December 31, 2018 was $0.450B, a 57.96% increase year-over-year.
  • ResMed annual net income for 2018 was $0.316B, a 7.8% decline from 2017.
  • ResMed annual net income for 2017 was $0.342B, a 2.87% decline from 2016.
  • ResMed annual net income for 2016 was $0.352B, a 0.14% decline from 2015.
ResMed Annual Net Income
(Millions of US $)
2018 $316
2017 $342
2016 $352
2015 $353
2014 $345
2013 $307
2012 $255
2011 $227
2010 $190
2009 $146
2008 $110
2007 $66
2006 $88
2005 $65
ResMed Quarterly Net Income
(Millions of US $)
Q2 2018 $125
Q1 2018 $106
Q4 2018 $110
Q3 2018 $110
Q2 2017 $10
Q1 2017 $86
Q4 2017 $102
Q3 2017 $88
Q2 2016 $77
Q1 2016 $76
Q4 2016 $83
Q3 2016 $91
Q2 2015 $96
Q1 2015 $83
Q4 2015 $87
Q3 2015 $91
Q2 2014 $91
Q1 2014 $83
Q4 2014 $88
Q3 2014 $90
Q2 2013 $87
Q1 2013 $81
Q4 2013 $73
Q3 2013 $85
Q2 2012 $78
Q1 2012 $71
Q4 2012 $77
Q3 2012 $65
Q2 2011 $63
Q1 2011 $51
Q4 2011 $58
Q3 2011 $53
Q2 2010 $58
Q1 2010 $57
Q4 2010 $53
Q3 2010 $49
Q2 2009 $46
Q1 2009 $42
Q4 2009 $45
Q3 2009 $39
Q2 2008 $34
Q1 2008 $28
Q4 2008 $30
Q3 2008 $30
Q2 2007 $27
Q1 2007 $24
Q4 2007 $28
Q3 2007 $-15
Q2 2006 $29
Q1 2006 $25
Q4 2006 $23
Q3 2006 $26
Q2 2005 $22
Q1 2005 $16
Q4 2005 $16
Q3 2005 $18
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.578B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.809B 26.28
Medtronic (MDT) Ireland $114.856B 16.79
Stryker (SYK) United States $69.039B 24.64
Boston Scientific (BSX) United States $49.279B 23.63
Baxter (BAX) United States $38.988B 25.01
Zimmer Biomet Holdings (ZBH) United States $25.460B 16.29
Smith & Nephew SNATS (SNN) United Kingdom $16.746B 0.00
Canopy Growth (CGC) Canada $16.646B 0.00
Aurora Cannabis (ACB) Canada $9.230B 65.07
Bio-Rad Laboratories (BIO) United States $8.754B 50.22
Perrigo (PRGO) Ireland $6.685B 10.84
Hill-Rom Holdings (HRC) United States $6.417B 19.85
Insulet (PODD) United States $4.971B 1666.40
GW Pharmaceuticals (GWPH) United Kingdom $4.857B 0.00
ICU Medical (ICUI) United States $4.694B 29.07
Haemonetics (HAE) United States $4.319B 38.31
Hutchison China MediTech (HCM) China $3.951B 0.00
Agios Pharmaceuticals (AGIO) United States $3.335B 0.00
NuVasive (NUVA) United States $3.048B 26.48
Neogen (NEOG) United States $3.014B 49.01
Quidel (QDEL) United States $2.477B 22.16
National Vision Holdings (EYE) United States $2.284B 44.94
Aphria (APHA) $1.955B 0.00
HEXO (HEXO) $1.502B 0.00
Phibro Animal Health (PAHC) United States $1.342B 19.28
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.222B 877.50
AtriCure (ATRC) United States $1.081B 0.00
Lantheus Holdings (LNTH) United States $0.962B 26.00
Omeros (OMER) United States $0.930B 0.00
PetIQ (PETQ) United States $0.874B 25.02
Cerus (CERS) United States $0.826B 0.00
MacroGenics (MGNX) United States $0.805B 0.00
NanoString Technologies (NSTG) United States $0.759B 0.00
Evolus (EOLS) United States $0.721B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.720B 24.51
TG Therapeutics (TGTX) United States $0.706B 0.00
OraSure Technologies (OSUR) United States $0.596B 25.95
Surmodics (SRDX) United States $0.585B 85.02
LeMaitre Vascular (LMAT) United States $0.554B 26.32
Meridian Bioscience (VIVO) United States $0.551B 16.42
Quanterix (QTRX) United States $0.500B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.344B 0.00
Insys Therapeutics (INSY) United States $0.321B 0.00
Utah Medical Products (UTMD) United States $0.319B 20.75
BioLife Solutions (BLFS) United States $0.308B 127.08
Vapotherm (VAPO) United States $0.283B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.223B 0.00
Owens & Minor (OMI) United States $0.214B 2.93
Zynex (ZYXI) United States $0.175B 18.69
Bovie Medical (APYX) United States $0.149B 0.00
Chimerix (CMRX) United States $0.129B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.123B 0.00
Surface Oncology (SURF) United States $0.112B 0.00
United-Guardian (UG) United States $0.088B 20.27
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.083B 0.00
Neurotrope (NTRP) United States $0.076B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 12.64